Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-08-041870
Filing Date
2008-02-28
Accepted
2008-02-28 16:41:04
Documents
9
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 971298
2 COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES dex121.htm EX-12.1 46900
3 SUBSIDIARIES OF THE REGISTRANT dex211.htm EX-21.1 1624
4 CONSENT OF INDEPENDANT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 13241
5 CERTIFICATION OF CEO PURSANT TO RULES 13A-14(A) AND 15D-14(A) dex311.htm EX-31.1 9691
6 CERTIFICATION OF CFO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) dex312.htm EX-31.2 9675
7 CERTIFICATION OF CEO PURSUANT TO 18 U.S.C. SECTION 1350 dex321.htm EX-32.1 2743
8 CERTIFICATION OF CFO PURSUANT TO 18 U.S.C. SECTION 1350 dex322.htm EX-32.2 2732
9 GRAPHIC g70017g18q57.jpg GRAPHIC 41366
  Complete submission text file 0001193125-08-041870.txt   1116444
Mailing Address 500 FORBES BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 500 FORBES BOULEVARD SOUTH SAN FRANCISCO CA 94080 6502663000
CELL GENESYS INC (Filer) CIK: 0000865231 (see all company filings)

EIN.: 943061375 | State of Incorp.: DE | Fiscal Year End: 1017
Type: 10-K | Act: 34 | File No.: 000-19986 | Film No.: 08651183
SIC: 2834 Pharmaceutical Preparations